Trulign Toric IOL

B + L places focus on innovation in pharma, surgical, vision careBausch + Lomb (B + L) is more than one of the oldest eye care companies in the industry. It is also one of the broadest, with portfolios in contact lenses, consumer eye products, cataract surgery, intraocular lenses, retina surgery, and a wide range of ophthalmic pharmaceutical products.
Accommodating IOL outcomes: Femtosecond laser or manual cataract removalPatients with accommodating IOLs implanted using a femtosecond laser-assisted procedure or manual cataract removal had similar excellent visual outcomes.
B+L introduces new innovations, productsBausch + Lomb presented several product innovations in pharmaceuticals, OTC offerings, IOLs, and surgical devices and equipment during the annual meeting of the American Academy of Ophthalmology.
Future of ophthalmic innovation is through R&D partnershipsOphthalmology has benefitted from many innovative new therapies in recent years. How do we continue to drive innovation? And how can we, as an industry, accelerate bringing new therapies to the marketplace?